课题基金 / 基金详情

B-CLL SUBGROUPS: MATURATION STAGE & GENE EXPRESSION

B-CLL SUBGROUPS: MATURATION STAGE & GENE EXPRESSION
B-CLL 亚群：成熟阶段
批准号：
7951906
负责人：
Nicholas Chiorazzi
金额：
$2.72万
依托单位：
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
项目状态：
已结题
起止时间：
2009-04-01 至 2010-03-31
来源：
https://reporter.nih.gov/project-details/7951906
关键词：
CategoriesChronic Lymphocytic LeukemiaClinicalClinical ResearchComputer Retrieval of Information on Scientific Projects DatabaseDiseaseFundingGene ExpressionGene MutationGrantInstitutionPatientsResearchResearch PersonnelResourcesSourceStagingSubgroupUnited States National Institutes of Healthbasedesign

项目摘要

项目成果

Nicholas Chiorazzi的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 最近的研究发现，疾病B型慢性淋巴细胞白血病(B-CLL)可以根据LG V基因突变状态和CD38的表达情况分为两个亚组。两组患者的临床病程不同。这项建议旨在更准确地了解这两大类B-CLL病例的不同之处。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Recent studies have found that the disease B-type chronic lymphocytic leukemia (B-CLL) can be divided into two subgroups based on lg V gene mutation status and CD 38 expression. The patients in these two groups follow different clinical courses. This proposal is designed to understand more precisely how these two broad categories of B-CLL cases differ.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Th17 generation, action and therapeutic relevance in chronic lymphocytic leukemia
Th17 generation, action and therapeutic relevance in chronic lymphocytic leukemia
Th17 generation, action and therapeutic relevance in chronic lymphocytic leukemia
Th17 generation, action and therapeutic relevance in chronic lymphocytic leukemia
海外基金